We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gentium Begins Pediatric Stem Cell Transplant Trial
Gentium has launched a Phase II/III trial with Defibrotide to prevent veno-occlusive disease (VOD), a complication of bone marrow and stem cell transplantation (SCT), in pediatric patients.